Why the study?
Does Tbx5 haploinsufficiency cause diastolic dysfunction in congenital heart disease?
Does Tbx5 haploinsufficiency cause diastolic dysfunction in congenital heart disease?
Tbx5 haploinsufficiency directly impairs cardiac diastolic function via Atp2a2 regulation, suggesting patients with structural congenital heart defects may have underlying functional anomalies requiring treatment.
May warrant diastolic evaluation in Holt-Oram syndrome; hypothesis-generating for Tbx5-targeted therapies in relaxation disorders.
At the end of every heartbeat, cardiac myocytes must relax to allow filling of the heart. Impaired relaxation is a significant factor in heart failure, but all pathways regulating the cardiac relaxation apparatus are not known. Haploinsufficiency of the T-box transcription factor Tbx5 in mouse and man causes congenital heart defects (CHDs) as part of Holt-Oram syndrome (HOS). Here, we show that haploinsufficiency of Tbx5 in mouse results in cell-autonomous defects in ventricular relaxation. Tbx5 dosage modulates expression of the sarco(endo)plasmic reticulum Ca(2+)-ATPase isoform 2a encoded by Atp2a2 and Tbx5 haploinsufficiency in ventricular myocytes results in impaired Ca(2+) uptake dynamics and Ca(2+) transient prolongation. We also demonstrate that Tbx5 can activate the Atp2a2 promoter. Furthermore, we find that patients with HOS have significant diastolic filling abnormalities. These results reveal a direct genetic pathway that regulates cardiac diastolic function, implying that patients with structural CHDs may have clinically important underlying anomalies in heart function that merit treatment.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: